Literature DB >> 728349

Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.

R Verloes, G Atassi, P Dumont, L Kanarek.   

Abstract

A comparative study of the effects of BCG, Micrococcus lysodeikticus, and a series of structurally related polysaccharides (complement triggers) on the non-specific and specific immune resistance against L1210 lymphoid leukaemia was carried out and commented on. In contrast with authors of earlier reports, we were unable to generate any effective non-specific or specific immunotherapy after the graft of 10(4) leukaemic cells to 8--10-week-old CDF1 mice. However, when mice were prevaccinated with irradiated (8 krad X-rays) cultured cells combined with 1 mg of bacterium or polysaccharide one month before grafting 10(4) cells, they were given an immunoprotection that was more pronounced with the i.p. than with the i.v. route. Prevaccinated mice were afforded a stronger immunoprotection when boosted repeatedly with 1mg injections of bacterium or polysaccharide after tumour challenge.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728349      PMCID: PMC2009791          DOI: 10.1038/bjc.1978.255

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

2.  Antitumour immunoprotection by an immunobacterial lectin approach.

Authors:  R Verloes; L Kanarek; G Atassi
Journal:  Eur J Cancer       Date:  1976-11       Impact factor: 9.162

3.  Biochemical properties that accompany the production of homogeneous antibody response: a general mechanism hypothesis [proceedings].

Authors:  R Verloes; M De Ridder; L Kanarek
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

Review 4.  Antitumor activity of Corynebacterium parvum.

Authors:  L Milas; M T Scott
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

6.  Letter: Reactions to BCG.

Authors:  P W Mansell
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

7.  Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.

Authors:  R K Johnson; D P Houchens; M R Gaston; A Goldin
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

Review 8.  Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications.

Authors:  M S Mitchell
Journal:  Biomedicine       Date:  1976

9.  Infection with Bacillus Calmette-Guérin activates murine thymus-independent (B) lymphocytes.

Authors:  B M Sultzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

10.  The induction of macrophage spreading: role of coagulation factors and the complement system.

Authors:  C Bianco; A Eden; Z A Cohn
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

View more
  1 in total

1.  Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.

Authors:  R Verloes; G Atassi; P Dumont; L Kanarek
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.